Advertisement
Home »

Durable benefit after treatment of obstructive benign prostatic hyperplasia with a novel drug-device combination product: 2-year outcomes from the EVEREST-I study.

Jun 26, 2023

ABOUT THE EXPERTS

  • Merycarla Pichardo

    URUS, Santo Domingo, Dominican Republic.

    Edwin Rijo

    Centro Médico Dr. Canela SRL, La Romana, Dominican Republic.

    Gustavo Espino

    Centro Especializado San Fernando, Panama City, Panama.

    Ramon Rodriguez Lay

    Edificio Royal Center, Panama City, Panama.

    Rafael Estrella

    Clínica Unión Medica, Santiago de los Caballeros, Dominican Republic.

    Cristian Gonzalez

    URUS, Santo Domingo, Dominican Republic.

    Marlin Fernandez

    URUS, Santo Domingo, Dominican Republic.

    David Soriano

    URUS, Santo Domingo, Dominican Republic.

    Ingris M Peralta

    URUS, Santo Domingo, Dominican Republic.

    Steven A Kaplan

    Department of Urology, Icahn School of Medicine at Mount Sinai, 625 Madison Avenue, 2nd Floor, New York, NY, 10065, USA. steven.kaplan@mountsinai.org.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement